Atoll GmbH
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD35m (Public information from Apr 2016)
Company register number HRB 500828
Weingarten Baden-Württemberg (HQ & founding location)